ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,640Medicare Part D Prescriptions Filled, Including Refills

Rank: 160 out of 1844

$683K Total Retail Price of All Prescriptions

Rank: 159 out of 1844

583 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 583 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

16% of this provider’s 583 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 7,802 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 383 249 1 1
AMLODIPINE BESYLATE 336 303 2 6
OMEPRAZOLE 335 211 3 5
LISINOPRIL 327 236 4 4
FUROSEMIDE 316 199 5 7
HYDROCODONE-ACETAMINOPHEN 315 211 S3 6 2
HYDROCHLOROTHIAZIDE 283 217 7 9
PRAVASTATIN SODIUM 229 180 8 10
WARFARIN SODIUM 227 215 9 13
SIMVASTATIN 210 141 10 3
CARVEDILOL 187 117 11 22
METFORMIN HCL 185 144 12 8
METOPROLOL SUCCINATE 169 133 13 14
PREDNISONE 158 111 14 40
POTASSIUM CHLORIDE 147 97 15 16
PROAIR HFA 129 80 16 45
LOVASTATIN 123 73 17 44
GABAPENTIN 121 97 18 15
METOPROLOL TARTRATE 120 110 19 11
TRAZODONE HCL 119 65 20 43
ATORVASTATIN CALCIUM 116 89 21 12
MELOXICAM 114 80 22 28
AZITHROMYCIN 110 74 23 37
SPIRIVA 104 77 24 57
CYMBALTA 103 36 25 36
PANTOPRAZOLE SODIUM 101 68 26 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 97 69 27 20
ALENDRONATE SODIUM 95 74 28 25
RANITIDINE HCL 94 51 29 38
LOSARTAN POTASSIUM 94 72 29 24
NEXIUM 88 24 31 31
ATENOLOL 87 58 32 17
TRICOR 87 20 32 109
TAMSULOSIN HCL 87 56 32 27
GLIMEPIRIDE 86 76 35 35
ZOLPIDEM TARTRATE 85 67 36 23
NAMENDA 85 85 36 33
FLUTICASONE PROPIONATE 84 41 38 50
PAROXETINE HCL 81 47 39 68
CITALOPRAM HBR 78 69 40 19
PLAVIX 78 68 40 61
LANTUS 77 55 42 42
FLUOXETINE HCL 75 50 43 41
CRESTOR 74 43 44 30
DIVALPROEX SODIUM 74 29 44 74
LANTUS SOLOSTAR 73 26 46 97
OXYCODONE-ACETAMINOPHEN 72 33 S2 47 94
ALLOPURINOL 71 52 48 29
POLYETHYLENE GLYCOL 3350 71 39 48 39
SINGULAIR 71 18 48 102
MIRTAZAPINE 67 48 51 49
CLOPIDOGREL 67 50 51 34
LAMOTRIGINE 63 0 53 174
LEVOFLOXACIN 62 39 54 78
OXYBUTYNIN CHLORIDE 62 52 54 103
ADVAIR DISKUS 60 38 56 51
CIPROFLOXACIN HCL 58 47 57 62
MORPHINE SULFATE ER 58 35 S2 57 107
METFORMIN HCL ER 58 35 57 46
SPIRONOLACTONE 57 41 60 60
KLOR-CON M20 57 56 60 54
MONTELUKAST SODIUM 55 25 62 195
CYCLOBENZAPRINE HCL 54 30 R 63 53
OLANZAPINE 53 50 64 117
INSULIN SYRINGE 53 15 64 111
RISPERIDONE 52 25 66 65
TRAMADOL HCL 51 38 67 18
CHLORTHALIDONE 51 38 67 176
DONEPEZIL HCL 51 51 67 26
NITROFURANTOIN MONO-MACRO 50 32 70 151
DEXILANT 50 50 70 228
AMOXICILLIN 50 24 70 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.